EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Trends of use and characterisation of anti-dementia drugs users: a large multinational-network population-based study

Carlen Reyes iD, Danielle Newby, Berta Raventós, Katia Verhamme, Mees Mosseveld, Daniel Prieto-Alhambra iD, Edward Burn, Talita Duarte-Salles

Age and Ageing · 2024

DOI: 10.1093/ageing/afae106 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Age and Ageing, 2024. Verfasst von Carlen Reyes und 7 weiteren Autor:innen. Beteiligte Einrichtung: Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain. Hauptthemen laut MEDLINE: Dementia. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Real World Epidemiology, Agency for Management of University and research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

An updated time-trend analysis of anti-dementia drugs (ADDs) is lacking. The aim of this study is to assess the incident rate (IR) of ADD in individuals with dementia using real-world data.

Setting

Primary care data (country/database) from the UK/CPRD-GOLD (2007–20), Spain/SIDIAP (2010–20) and the Netherlands/IPCI (2008–20), standardised to a common data model.

Methods

Cohort study. Participants: dementia patients ≥40 years old with ≥1 year of previous data. Follow-up: until the end of the study period, transfer out of the catchment area, death or incident prescription of rivastigmine, galantamine, donepezil or memantine. Other variables: age/sex, type of dementia, comorbidities. Statistics: overall and yearly age/sex IR, with 95% confidence interval, per 100,000 person-years (IR per 105 PY (95%CI)).

Results

We identified a total of (incident anti-dementia users/dementia patients) 41,024/110,642 in UK/CPRD-GOLD, 51,667/134,927 in Spain/SIDIAP and 2,088/17,559 in the Netherlands/IPCI. In the UK, IR (per 105 PY (95%CI)) of ADD decreased from 2007 (30,829 (28,891–32,862)) to 2010 (17,793 (17,083–18,524)), then increased up to 2019 (31,601 (30,483 to 32,749)) and decrease in 2020 (24,067 (23,021–25,148)). In Spain, IR (per 105 PY (95%CI)) of ADD decreased by 72% from 2010 (51,003 (49,199–52,855)) to 2020 (14,571 (14,109–15,043)). In the Netherlands, IR (per 105 PY (95%CI)) of ADD decreased by 77% from 2009 (21,151 (14,967–29,031)) to 2020 (4763 (4176–5409)). Subjects aged ≥65–79 years and men (in the UK and the Netherlands) initiated more frequently an ADD.

Conclusions

Treatment of dementia remains highly heterogeneous. Further consensus in the pharmacological management of patients living with dementia is urgently needed.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DementiaHumansMaleFemaleAgedAged, 80 and overMiddle AgedNetherlandsDatabases, FactualTime FactorsNootropic AgentsSpainUnited KingdomPractice Patterns, Physicians'Age FactorsDrug Utilization

Stichwörter der Autor:innen

cohort studiesdementiadrug utilization studiesolder people

Substanzen

Nootropic Agents

Autor:innen und Institutionen

  • Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain.
  • Sardenya Primary Health Care Center, EAP Sardenya- Research Institute Sant Pau (EAP Sardenya-IR Sant Pau), Barcelona, Spain.
  • Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford, Botnar Research Centre, Windmill Road, Oxford, UK.
  • Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Department of Medical Informatics, Erasmus Medical Center University, Rotterdam, Netherlands.

ORCID-Profile: Carlen Reyes, Daniel Prieto-Alhambra

Förderung

  • Real World Epidemiology
  • Agency for Management of University and research

Zitieren

APA

Reyes, C., Newby, D., Raventós, B., Verhamme, K., Mosseveld, M., Prieto-Alhambra, D., Burn, E., & Duarte-Salles, T. (2024). Trends of use and characterisation of anti-dementia drugs users: a large multinational-network population-based study. Age and Ageing. https://doi.org/10.1093/ageing/afae106

Vancouver

Reyes C, Newby D, Raventós B, Verhamme K, Mosseveld M, Prieto-Alhambra D, et al. Trends of use and characterisation of anti-dementia drugs users: a large multinational-network population-based study. Age and Ageing. 2024. doi:10.1093/ageing/afae106

BibTeX
@article{Reyes2024,
  author = {Reyes, Carlen and Newby, Danielle and Raventós, Berta and Verhamme, Katia and Mosseveld, Mees and Prieto-Alhambra, Daniel and Burn, Edward and Duarte-Salles, Talita},
  title = {Trends of use and characterisation of anti-dementia drugs users: a large multinational-network population-based study},
  journal = {Age and Ageing},
  year = {2024},
  doi = {10.1093/ageing/afae106}
}
Kostenlos starten →